Lisa Cook sues Trump over firing attempt, emergency hearing set
Investing.com - Truist Securities raised its price target on Stryker (NYSE:SYK) to $415.00 from $410.00 on Monday, while maintaining a Hold rating on the medical technology company’s stock. According to InvestingPro data, analysts have set price targets ranging from $316 to $465, with 15 analysts recently revising their earnings estimates upward.
The price target adjustment follows Stryker’s double-digit revenue and earnings per share beat in its second quarter results, which prompted the company to raise its own guidance. The company, currently valued at $145.6 billion, has demonstrated strong performance with 11.4% revenue growth over the last twelve months. InvestingPro analysis indicates the stock is trading above its Fair Value, with 13 additional exclusive insights available to subscribers.
Truist noted some minor concerns including NARI destocking, softer knee growth, and longer than expected medical supply constraints, but characterized these issues as temporary.
The firm highlighted Stryker’s progress toward delivering 100 basis points of margin expansion in 2025 on approximately 10% organic revenue growth, describing the company as a high-quality large-cap with a diversified revenue profile and above-peer revenue and earnings growth.
Despite the positive assessment, Truist maintained its Hold rating, indicating it prefers other large-cap companies in its coverage universe with faster growth prospects.
In other recent news, Stryker Corporation announced its second-quarter earnings for 2025, surpassing analyst expectations. The company reported an earnings per share (EPS) of $3.13, which exceeded the forecasted $3.07, resulting in a 1.95% surprise. Additionally, Stryker’s revenue reached $6.02 billion, outperforming the anticipated $5.94 billion. These results highlight a positive performance for the quarter. Despite the strong earnings and revenue figures, Stryker’s stock experienced a decline during regular trading hours. However, there was a slight recovery in aftermarket trading. These developments are part of the latest updates for the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.